Lateral Hypothalamus Orexin Hypocretin Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Lateral Hypothalamus Orexin (Hypocretin) Neurons are critical for arousal, wakefulness, energy homeostasis, and reward processing. Loss of these neurons causes narcolepsy.
| Property |
Value |
| Category |
Hypothalamic Neuropeptide Neurons |
| Location |
Lateral hypothalamus, perifornical area |
| Cell Types |
Orexin-A/Hypocretin-1 and Orexin-B/Hypocretin-2 neurons |
| Primary Neurotransmitters |
Orexin-A, Orexin-B (hypocretins) |
| Key Markers |
HCRT, OX1R, OX2R, Hcrt |
Orexin neurons project widely throughout the brain and regulate:
- Wakefulness: Maintain arousal state, prevent sleep transitions
- Energy Homeostasis: Monitor metabolic status, regulate feeding
- Reward Processing: Modulate dopamine system, motivated behavior
- Autonomic Functions: Control heart rate, respiration, thermoregulation
Orexin neurons are localized primarily in the:
- Lateral hypothalamus (LH)
- Perifornical nucleus (PeF)
- Dorsomedial hypothalamus (DMH)
Projections go to:
- Tuberomammillary nucleus (histamine)
- Locus coeruleus (norepinephrine)
- Raphe nuclei (serotonin)
- VTA (dopamine)
- Basal forebrain (acetylcholine)
- Primary Cause: Loss of orexin neurons (∼90%)
- Pathology: Reduced orexin-A in CSF (95% specificity)
- Symptoms: Excessive daytime sleepiness, cataplexy, sleep paralysis
- Orexin dysregulation contributes to sleep disturbances
- Sleep fragmentation common in AD patients
- Orexin antagonists may improve sleep in AD
- Sleep disorders in 60-90% of PD patients
- REM behavior disorder often precedes motor symptoms
- Orexin system alterations documented
- Orexin regulates appetite and energy expenditure
- Reduced orexin signaling may contribute to obesity
- Orexin antagonists investigated for weight management
- High firing rate during active wake
- Reduced firing during NREM sleep
- Silent during REM sleep
- Activity correlates with metabolic state
- Modafinil: Wake-promoting (unknown orexin mechanism)
- Pitolisant: Histamine H3 inverse agonist
- Orexin Receptor Agonists: For narcolepsy (e.g., lemborexant mechanism)
- Orexin Cell Transplantation: Experimental
- Gene Therapy: AAV-based orexin expression
- Dual orexin receptor antagonists (DORAs): suvorexant, lemborexant, daridorexant
- Used for insomnia (opposite of narcolepsy)
The study of Lateral Hypothalamus Orexin Hypocretin Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Sakurai T. Orexin and narcolepsy. Nat Rev Neurosci. 2007;8(3):171-181. PMID:17351065
[2] Peyron C, et al. Orexin neurons in narcolepsy. Nature. 2000;403(6772):722-727. PMID:10683747
[3] Saper CB, et al. Orexin system in sleep-wake control. FEBS J. 2010;277(1):1-9.
[4] Tsujino N, Sakurai T. Orexin/Hypocretin. Pharmacol Rev. 2009;61(2):162-176.